Erika Rosivatz
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Health, Toxicology and Mutagenesis top 5%
- Physiology
- Co-authors
- Karl‐Friedrich BeckerHeinz HöflerIngrid BeckerAndreas KortenkampFrances OrtonMartin ScholzeBirgit LuberRaymonde Busch
- Topics
- Wnt/β-catenin signaling in development and cancer (7 papers)Cancer Cells and Metastasis (5 papers)Effects and risks of endocrine disrupting chemicals (4 papers)
- Partner nations
- United KingdomGermanyAustria
In The Last Decade
Erika Rosivatz
25 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 114
- Molecular Biology 1.1k
- Oncology 616
- Cancer Research 317
- Health, Toxicology and Mutagenesis 246
- Physiology 173
Countries citing papers authored by Erika Rosivatz
This map shows the geographic impact of Erika Rosivatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Rosivatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Rosivatz more than expected).
Fields of papers citing papers by Erika Rosivatz
This network shows the impact of papers produced by Erika Rosivatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Rosivatz. The network helps show where Erika Rosivatz may publish in the future.
Co-authorship network of co-authors of Erika Rosivatz
This figure shows the co-authorship network connecting the top 25 collaborators of Erika Rosivatz. A scholar is included among the top collaborators of Erika Rosivatz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Rosivatz. Erika Rosivatz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 101 | |
| 3 | 39 | |
| 4 | 20 | |
| 5 | 144 | |
| 6 | 42 | |
| 7 | 279 | |
| 8 | 25 | |
| 9 | 6 | |
| 10 | 4 | |
| 11 | 24 | |
| 12 | 4 | |
| 13 | 145 | |
| 14 | 7 | |
| 15 | 110 | |
| 16 | 13 | |
| 17 | 118 | |
| 18 | 13 | |
| 19 | 63 | |
| 20 | 492 |
About Erika Rosivatz
Erika Rosivatz is a scholar working on Health, Toxicology and Mutagenesis, Molecular Biology and Oncology, having authored 25 papers that have together received 1.8k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (7 papers), Cancer Cells and Metastasis (5 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). The work is most often cited by research in Oncology (616 citations), Cancer Research (317 citations) and Health, Toxicology and Mutagenesis (246 citations). Erika Rosivatz has collaborated with scholars based in United Kingdom, Germany and Austria. Frequent co-authors include Karl‐Friedrich Becker, Heinz Höfler, Ingrid Becker, Andreas Kortenkamp, Frances Orton, Martin Scholze, Birgit Luber, Raymonde Busch, Katja Specht and Rüdiger Woscholski. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.